142 related articles for article (PubMed ID: 10787085)
1. Protein expression of bax, bcl-2, and p53 in patients with non-Hodgkin's gastric lymphoma: prognostic significance.
Charalambous GK; Gomatos IP; Konstadoulakis MM; Messaris EG; Manouras AJ; Apostolou AE; Leandros EA; Karayannis MK; Androulakis GA
World J Surg; 2000 May; 24(5):608-14. PubMed ID: 10787085
[TBL] [Abstract][Full Text] [Related]
2. HLA-DR antigen and bax protein expression in patients with primary non-Hodgkin's gastric lymphoma.
Darom A; Gomatos IP; Leandros E; Xatziyiannis E; Fotiadis C; Konstadoulakis MM
Hybrid Hybridomics; 2004 Apr; 23(2):87-92. PubMed ID: 15165481
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of bcl-2, bax, and p53 expression in diffuse large B-cell lymphoma.
Sohn SK; Jung JT; Kim DH; Kim JG; Kwak EK; Park Ti; Shin DG; Sohn KR; Lee KB
Am J Hematol; 2003 Jun; 73(2):101-7. PubMed ID: 12749011
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of CD95, P53, and BCL2 expression in extranodal non-Hodgkin's lymphoma.
Chatzitolios A; Venizelos I; Tripsiannis G; Anastassopoulos G; Papadopoulos N
Ann Hematol; 2010 Sep; 89(9):889-96. PubMed ID: 20352431
[TBL] [Abstract][Full Text] [Related]
5. Inverse correlation between the expression of bcl-2 and p53 proteins in primary gastric lymphoma.
Nakamura S; Akazawa K; Kinukawa N; Yao T; Tsuneyoshi M
Hum Pathol; 1996 Mar; 27(3):225-33. PubMed ID: 8600035
[TBL] [Abstract][Full Text] [Related]
6. Expression of p53, p21/waf1, bcl-2, bax, Rb and Ki67 proteins in Hodgkin's lymphomas.
Kanavaros P; Stefanaki K; Vlachonikolis J; Eliopoulos G; Kakolyris S; Rontogianni D; Gorgoulis V; Georgoulias V
Histol Histopathol; 2000 Apr; 15(2):445-53. PubMed ID: 10809363
[TBL] [Abstract][Full Text] [Related]
7. P53, bcl-2, and bax: their relationship and effect on prognosis in early stage epithelial ovarian carcinoma.
Skirnisdóttir I; Sorbe B; Seidal T
Int J Gynecol Cancer; 2001; 11(2):147-58. PubMed ID: 11328414
[TBL] [Abstract][Full Text] [Related]
8. Clinical role of Bcl-2, Bax, or p53 overexpression in peripheral T-cell lymphomas.
Jung JT; Kim DH; Kwak EK; Kim JG; Park TI; Sohn SK; Do YR; Kwon KY; Song HS; Park EH; Lee KB
Ann Hematol; 2006 Sep; 85(9):575-81. PubMed ID: 16673127
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Bax and Bcl-2 expression in p53-immunopositive breast cancers.
Krajewski S; Thor AD; Edgerton SM; Moore DH; Krajewska M; Reed JC
Clin Cancer Res; 1997 Feb; 3(2):199-208. PubMed ID: 9815673
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis and apoptosis-related protein (p53, bcl-2, and bax) expression versus response of gastric adenocarcinomas to paclitaxel and carboplatin chemotherapy.
Giatromanolaki A; Stathopoulos GP; Koukourakis MI; Rigatos S; Vrettou E; Kittas C; Fountzilas G; Sivridis E
Am J Clin Oncol; 2001 Jun; 24(3):222-6. PubMed ID: 11404489
[TBL] [Abstract][Full Text] [Related]
11. Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2.
Schuyer M; van der Burg ME; Henzen-Logmans SC; Fieret JH; Klijn JG; Look MP; Foekens JA; Stoter G; Berns EM
Br J Cancer; 2001 Nov; 85(9):1359-67. PubMed ID: 11720475
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of Bax protein expression in diffuse aggressive non-Hodgkin's lymphoma.
Gascoyne RD; Krajewska M; Krajewski S; Connors JM; Reed JC
Blood; 1997 Oct; 90(8):3173-8. PubMed ID: 9376600
[TBL] [Abstract][Full Text] [Related]
13. Bax protein expression in colorectal cancer: association with p53, bcl-2 and patterns of relapse.
Giatromanolaki A; Sivridis E; Stathopoulos GP; Fountzilas G; Kalofonos HP; Tsamandas A; Vrettou E; Scopa C; Polychronidis A; Simopoulos K; Koukourakis MI
Anticancer Res; 2001; 21(1A):253-9. PubMed ID: 11299743
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of Bax, Bcl-2, and p53 expressions in cervical squamous cell carcinoma treated by radiotherapy.
Wootipoom V; Lekhyananda N; Phungrassami T; Boonyaphiphat P; Thongsuksai P
Gynecol Oncol; 2004 Sep; 94(3):636-42. PubMed ID: 15350352
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of the expression of p53, bcl-2, and bax oncoproteins, and neovascularization in patients with radically resected non-small-cell lung cancer.
Apolinario RM; van der Valk P; de Jong JS; Deville W; van Ark-Otte J; Dingemans AM; van Mourik JC; Postmus PE; Pinedo HM; Giaccone G
J Clin Oncol; 1997 Jun; 15(6):2456-66. PubMed ID: 9196162
[TBL] [Abstract][Full Text] [Related]
16. Bax expression as a prognostic marker of postoperative chemoradiotherapy for patients with esophageal cancer.
Ikeguchi M; Maeta M; Kaibara N
Int J Mol Med; 2001 Apr; 7(4):413-7. PubMed ID: 11254884
[TBL] [Abstract][Full Text] [Related]
17. Expression of apoptosis-regulating proteins and outcome of esophageal cancer patients treated by combined therapy modalities.
Sarbia M; Stahl M; Fink U; Willers R; Seeber S; Gabbert HE
Clin Cancer Res; 1998 Dec; 4(12):2991-7. PubMed ID: 9865911
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of Bcl-2 and p53 expression in gastric cancer.
Lee HK; Lee HS; Yang HK; Kim WH; Lee KU; Choe KJ; Kim JP
Int J Colorectal Dis; 2003 Nov; 18(6):518-25. PubMed ID: 12811476
[TBL] [Abstract][Full Text] [Related]
19. p53, bcl-2 and bax abnormalities in non-Hodgkin's lymphomas of the head and neck.
Miyauchi M; Higashikawa K; Sugiyama M; Harada T; Sasaki N; Ishikawa T
J Oral Pathol Med; 2000 Apr; 29(4):180-5. PubMed ID: 10766396
[TBL] [Abstract][Full Text] [Related]
20. Expression of p53, Bcl-2, and Bax in Cd34+ cells recovering after chemotherapy.
Toefili L; Rutella S; Putzulu R; Rumi C; Leone G; Larocca LM; Maggiano N
Blood; 1998 Dec; 92(12):4880-1. PubMed ID: 9988550
[No Abstract] [Full Text] [Related]
[Next] [New Search]
